Owning the Genome

David B. Resnik

Description

DNA patenting has emerged as a hot topic in science policy and bioethics as private companies and government agencies spend billions of dollars on genetic research and development in a race to identify, sequence, and analyze DNA from human, animal, and plant species. David B. Resnik's Owning the Genome explores the ethical, social, philosophical, theological, and policy issues surrounding DNA patenting and develops a comprehensive approach to the topic. Resnik considers arguments for and against DNA patenting and concludes that only a patent on a whole human genome would be inherently immoral, while the morality of other DNA patents depends on their consequences for science, medicine, agriculture, industry, and society. He also stresses the importance of government regulations and policies in order to minimize the harmful effects of patenting while promoting the beneficial ones.

Acknowledgments

Legal Disclaimers

Disclosure Statement

1. Introduction and Overview

2. DNA and Biotechnology

3. DNA as Intellectual Property

4. Arguments for DNA Patenting

5. Patenting Nature?

6. DNA Patents and Human Dignity

7. DNA Patents and Scientific Progress

8. DNA Patents and Medicine

9. DNA Patents and Agriculture

10. Conclusions and Policy Recommendations

Notes

References

Index

Sujets

• Philosophie
• Éthique et morale
• Ethique et morale
• Philosophy of science

Informations

• Publié par: State University of New York Press
• Date de parution: 01 février 2012
• Nombre de lectures: 0
• EAN13: 9780791485941
• Langue: English
• Poids de l'ouvrage: 2 Mo

Extrait

OWNINGTHE GENOME A Moral Analysis of DNA Patenting

DAVID B. RESNIK

Owning the Genome

This page intentionally left blank.

Owning the Genome

A Moral Analysis of DNA Patenting

David B. Resnik

State University of New York Press

Published by State University of New York Press, Albany

© 2004 State University of New York

All rights reserved

Printed in the United States of America

No part of this book may be used or reproduced in any manner whatsoever without written permission. No part of this book may be stored in a retrieval system or transmitted in any form or by any means including electronic, electrostatic, magnetic tape, mechanical, photocopying, recording, or otherwise without the prior permission in writing of the publisher.

For information, address State University of New York Press, 90 State Street, Suite 700, Albany, NY 12207

Production by Michael Haggett Marketing by Michael Campochiaro

Library of Congress CataloginginPublication Data

Resnik, David B. Owning the genome : a moral analysis of DNA patenting / David B. Resnik p. cm. Includes bibliographical references and index. ISBN 0-7914-5931-4 (alk. paper) — ISBN 0-7914-5932-2 (pbk. : alk. paper) 1. Patent laws and legislation—United States. 2. Biotechnology industries—Law and legislation—United States. 3. Recombinant DNA—Patents—Moral and ethical aspects. 4. Human genome—Patents—Moral and ethical aspects. I. Title.

KF3133.B56R47 2004 346.7304'86—dc22

10 9 8 7 6 5 4 3 2 1

2004041648

For Susan, Peter, and Michael

This page intentionally left blank.

Acknowledgments

Legal Disclaimers

Disclosure Statement

1 Introduction and Overview

2 DNA and Biotechnology

Contents

3 DNA as Intellectual Property

4 Arguments for DNA Patenting

5 Patenting Nature?

6 DNA Patents and Human Dignity

7 DNA Patents and Scientific Progress

8 DNA Patents and Medicine

9 DNA Patents and Agriculture

10 Conclusions and Policy Recommendations

Notes

References

Index

vii

i

x

xi

xiii

1

13

31

63

73

93

131

155

177

195

203

211

231

This page intentionally left blank.

Acknowledgments

I would like to acknowledge individuals and organizations that have helped me gather information for this book or who have given me critical feedback. Those deserving recognition include: Ellen Clayton, Ronald Cole-Turner, Ken De Ville, John Doll, Rebecca Eisenberg, Lila Feisee, Myron Genel, Paul Gilman, Frank Grassler, Mark Hanson, Pamela Langer, David Magnus, Ron Mahurin, Jon Merz, Jeremy Rifkin, Todd Savitt, Richard Sharp, Jeremy Sug- arman, John Wiley, Stephen Wilkinson, several anonymous reviewers, the National Human Genome Research Institute, and the U.S. Office of Patents and Trademarks. The ideas and opinions contained in this book do not nec- essarily reflect their views. Any mistakes of fact or reasoning are my own. I would also like to thank Kristy Aro, Georganne Perry, and Sarah Potter for help in preparing the manuscript.

i

x